Company Filing History:
2 out of 151 
1 out of 2,488 
1 out of 1,157 Years Active: 2015-2019
Title: Nevena Tzekova: Pioneering Advances in Peripheral Nerve Treatment
Introduction
Nevena Tzekova, an innovator based in Düsseldorf, Germany, has made significant contributions to the field of neurology through her groundbreaking inventions. With three patents to her name, Tzekova is recognized for her pioneering work on the treatment of demyelinating peripheral neuropathies, focusing on utilizing polyclonal immunoglobulin G (IgG) to stimulate nerve repair and regeneration.
Latest Patents
Tzekova's latest patent addresses the role of polyclonal IgG in promoting Schwann cell maturation, differentiation, and myelin production. The invention presents methods for treating non-idiopathic, demyelinating peripheral neuropathies in mammals, specifically those that are not immune-mediated or infection-mediated. This innovative approach provides options for treating peripheral nerve trauma and toxin-induced peripheral neuropathies. The invention further details how a composition of polyclonal IgGs can be directly applied to a peripheral nerve cell, inducing the maturation and differentiation necessary for myelin expression and overall cell survival.
Career Highlights
Throughout her career, Nevena Tzekova has worked with notable organizations, including Baxalta GmbH. Her work there has been instrumental in advancing therapeutic strategies for nerve-related disorders, encapsulating her dedication to enhancing the quality of treatment options available for patients suffering from peripheral nerve injuries.
Collaborations
Tzekova has collaborated with distinguished colleagues in her field, including Patrick Küry and Hans-Peter Hartung. These professional relationships have fostered an environment of innovation and critical research, propelling advancements in the understanding and treatment of demyelinating conditions.
Conclusion
Nevena Tzekova stands out as a formidable force in the arena of neurological innovation. Her patents signify a crucial step forward in treating challenging conditions that affect peripheral nerves, marking her contributions as vital to the future of medical science. As she continues her work, the potential impact of her innovations promises to benefit countless individuals impacted by nerve damage.